Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Total Current Liabilities (2021 - 2025)

Historic Total Current Liabilities for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $228.6 million.

  • LifeStance Health's Total Current Liabilities rose 507.83% to $228.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $228.6 million, marking a year-over-year increase of 507.83%. This contributed to the annual value of $228.9 million for FY2024, which is 1282.23% up from last year.
  • LifeStance Health's Total Current Liabilities amounted to $228.6 million in Q3 2025, which was up 507.83% from $242.3 million recorded in Q2 2025.
  • LifeStance Health's Total Current Liabilities' 5-year high stood at $242.3 million during Q2 2025, with a 5-year trough of $105.2 million in Q3 2021.
  • For the 5-year period, LifeStance Health's Total Current Liabilities averaged around $179.2 million, with its median value being $192.0 million (2023).
  • Per our database at Business Quant, LifeStance Health's Total Current Liabilities surged by 11454.5% in 2023 and then plummeted by 969.8% in 2024.
  • Quarter analysis of 5 years shows LifeStance Health's Total Current Liabilities stood at $116.8 million in 2021, then skyrocketed by 50.75% to $176.0 million in 2022, then increased by 15.27% to $202.9 million in 2023, then grew by 12.82% to $228.9 million in 2024, then fell by 0.14% to $228.6 million in 2025.
  • Its last three reported values are $228.6 million in Q3 2025, $242.3 million for Q2 2025, and $207.4 million during Q1 2025.